Related Experiment Videos
What's New in Pigmentary Disorders
Raheel Zubair1, Alexis B Lyons1, Gautham Vellaichamy2
1Department of Dermatology, Henry Ford Hospital System, 3031 West Grand Boulvard, Suite 800, Detroit, MI 48202, USA.
Dermatologic Clinics
|March 10, 2019
Abstract:
Pigmentary disorders are common and can be very distressing to patients. There is a need for better, standardized therapies. The authors review the most recent data for topical, systemic, light, and laser treatments for vitiligo, melasma, and postinflammatory hyperpigmentation. There is a paucity of large-scale, well-designed, randomized, controlled trials for these treatments. Treatment options are often drawn from smaller trials and case series. The treatments described in this article are promising candidates for larger follow-up studies.